Patients with central nervous system lymphoma undergoing thiotepa, busulfan, and cyclophosphamide-conditioned autologous stem cell transplantation are at a higher risk for DNA virus infections than patients with systemic non-Hodgkin lymphoma receiving traditional conditioning Meeting Abstract


Authors: Scordo, M.; Morjaria, S. M.; Bhatia, A.; Littmann, E. R.; Maloy, M.; DeAngelis, L.; Giralt, S. A.; Taur, Y.; Sauter, C. S.
Abstract Title: Patients with central nervous system lymphoma undergoing thiotepa, busulfan, and cyclophosphamide-conditioned autologous stem cell transplantation are at a higher risk for DNA virus infections than patients with systemic non-Hodgkin lymphoma receiving traditional conditioning
Meeting Title: 59th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 130
Issue: Suppl. 1
Meeting Dates: 2017 Dec 9-12
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2017-12-07
Language: English
ACCESSION: WOS:000432419704120
PROVIDER: wos
Notes: Meeting Abstract: 4528 -- Source: Wos